Free Trial

OmniStar Financial Group Inc. Makes New $535,000 Investment in Trupanion, Inc. (NASDAQ:TRUP)

Trupanion logo with Finance background

OmniStar Financial Group Inc. acquired a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 12,751 shares of the financial services provider's stock, valued at approximately $535,000.

Other large investors have also modified their holdings of the company. Wellington Management Group LLP boosted its position in shares of Trupanion by 34.6% in the 4th quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider's stock valued at $74,862,000 after purchasing an additional 630,155 shares during the period. Check Capital Management Inc. CA boosted its holdings in shares of Trupanion by 34.8% in the first quarter. Check Capital Management Inc. CA now owns 32,355 shares of the financial services provider's stock valued at $893,000 after acquiring an additional 8,355 shares during the period. Capstone Investment Advisors LLC purchased a new position in shares of Trupanion during the first quarter worth approximately $269,000. GSA Capital Partners LLP increased its holdings in shares of Trupanion by 376.5% in the 1st quarter. GSA Capital Partners LLP now owns 80,046 shares of the financial services provider's stock valued at $2,210,000 after acquiring an additional 63,247 shares during the period. Finally, Texas Permanent School Fund Corp raised its position in Trupanion by 1.8% in the 1st quarter. Texas Permanent School Fund Corp now owns 31,269 shares of the financial services provider's stock valued at $863,000 after purchasing an additional 561 shares during the last quarter.

Wall Street Analyst Weigh In

Several brokerages have issued reports on TRUP. Piper Sandler raised their price objective on shares of Trupanion from $38.00 to $45.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 2nd. Evercore ISI raised Trupanion to a "strong-buy" rating in a report on Friday, August 9th. Bank of America upped their price objective on Trupanion from $47.00 to $56.00 and gave the company a "buy" rating in a research note on Friday, September 20th. Northland Securities increased their price objective on Trupanion from $35.00 to $45.00 and gave the stock a "market perform" rating in a research report on Thursday, September 19th. Finally, Stifel Nicolaus boosted their target price on Trupanion from $30.00 to $40.00 and gave the company a "hold" rating in a report on Monday, September 23rd. Four analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $41.83.

View Our Latest Stock Analysis on Trupanion

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 640 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Margaret Tooth sold 7,500 shares of the business's stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Fawwad Qureshi sold 640 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total transaction of $27,596.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,764 shares of company stock worth $405,238. Corporate insiders own 5.50% of the company's stock.

Trupanion Stock Performance

NASDAQ:TRUP traded down $0.64 during mid-day trading on Friday, reaching $54.84. The stock had a trading volume of 1,441,819 shares, compared to its average volume of 687,585. Trupanion, Inc. has a twelve month low of $19.14 and a twelve month high of $55.74. The business has a 50 day simple moving average of $44.93 and a 200 day simple moving average of $34.23. The firm has a market capitalization of $2.31 billion, a price-to-earnings ratio of -121.86 and a beta of 1.73. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The business had revenue of $314.80 million during the quarter, compared to the consensus estimate of $309.33 million. During the same period in the prior year, the business posted ($0.33) EPS. The company's revenue for the quarter was up 16.3% on a year-over-year basis. On average, analysts expect that Trupanion, Inc. will post -0.34 earnings per share for the current fiscal year.

Trupanion Profile

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

→ Watch this before it gets removed (From Porter & Company) (Ad)

Should you invest $1,000 in Trupanion right now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet (GOOGL) is in the midst of a year-end rally, climbing 10% since September, and some analysts predict it could gain another 30% by Christmas!

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines